Global Open-Angle Glaucoma Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prostaglandin Analogs (PGAs)
1.4.3 Combination of PGAs
1.4.4 Other
1.5 Market by Application
1.5.1 Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Open-Angle Glaucoma Therapeutics Market Perspective (2015-2026)
2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Regions
2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Open-Angle Glaucoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Open-Angle Glaucoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Market Size
3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
3.2.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2019
3.3 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
3.5 Date of Enter into Open-Angle Glaucoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
6.2 Open-Angle Glaucoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
7.2 Open-Angle Glaucoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
8.2 Open-Angle Glaucoma Therapeutics Key Players in China (2019-2020)
8.3 China Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
8.4 China Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
9.2 Open-Angle Glaucoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
10.2 Open-Angle Glaucoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
11.2 Open-Angle Glaucoma Therapeutics Key Players in India (2019-2020)
11.3 India Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
11.4 India Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
12.2 Open-Angle Glaucoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Aerie Pharmaceuticals Inc.
13.1.1 Aerie Pharmaceuticals Inc. Company Details
13.1.2 Aerie Pharmaceuticals Inc. Business Overview and Its Total Revenue
13.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
13.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020))
13.1.5 Aerie Pharmaceuticals Inc. Recent Development
13.2 Allergan Plc
13.2.1 Allergan Plc Company Details
13.2.2 Allergan Plc Business Overview and Its Total Revenue
13.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
13.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
13.2.5 Allergan Plc Recent Development
13.3 Bausch Health Companies, Inc.
13.3.1 Bausch Health Companies, Inc. Company Details
13.3.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
13.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
13.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
13.3.5 Bausch Health Companies, Inc. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
13.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Details
13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
13.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
13.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
13.5.5 Pfizer Inc. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Open-Angle Glaucoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
Table 3. Ranking of Global Top Open-Angle Glaucoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prostaglandin Analogs (PGAs)
Table 6. Key Players of Combination of PGAs
Table 7. Key Players of Other
Table 8. Global Open-Angle Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Open-Angle Glaucoma Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Open-Angle Glaucoma Therapeutics Players
Table 19. Global Open-Angle Glaucoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Open-Angle Glaucoma Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2019)
Table 22. Global Open-Angle Glaucoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
Table 25. Date of Enter into Open-Angle Glaucoma Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Open-Angle Glaucoma Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 35. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 37. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 41. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 47. China Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 49. China Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 53. Japan Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 65. India Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 67. India Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 71. Central & South America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 75. Aerie Pharmaceuticals Inc. Company Details
Table 76. Aerie Pharmaceuticals Inc. Business Overview
Table 77. Aerie Pharmaceuticals Inc. Product
Table 78. Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 79. Aerie Pharmaceuticals Inc. Recent Development
Table 80. Allergan Plc Company Details
Table 81. Allergan Plc Business Overview
Table 82. Allergan Plc Product
Table 83. Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 84. Allergan Plc Recent Development
Table 85. Bausch Health Companies, Inc. Company Details
Table 86. Bausch Health Companies, Inc. Business Overview
Table 87. Bausch Health Companies, Inc. Product
Table 88. Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 89. Bausch Health Companies, Inc. Recent Development
Table 90. Novartis AG Company Details
Table 91. Novartis AG Business Overview
Table 92. Novartis AG Product
Table 93. Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 94. Novartis AG Recent Development
Table 95. Pfizer Inc. Company Details
Table 96. Pfizer Inc. Business Overview
Table 97. Pfizer Inc. Product
Table 98. Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 99. Pfizer Inc. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Open-Angle Glaucoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Prostaglandin Analogs (PGAs) Features
Figure 3. Combination of PGAs Features
Figure 4. Other Features
Figure 5. Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Open-Angle Glaucoma Therapeutics Report Years Considered
Figure 11. Global Open-Angle Glaucoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Open-Angle Glaucoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Open-Angle Glaucoma Therapeutics Revenue in 2019
Figure 18. North America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Aerie Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Aerie Pharmaceuticals Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 27. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Plc Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 29. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bausch Health Companies, Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 31. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis AG Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed